Serina Therapeutics, Inc. Accounts Payable and Other Accrued Liabilities, Current
Serina Therapeutics, Inc. (SER) had Accounts Payable and Other Accrued Liabilities, Current of $261.00 thousand as of 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Notes › Payables and Accruals
us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent · last filed 2022-11-10
- 2022-09-30: Accounts Payable and Other Accrued Liabilities, Current $261.00K.
- 2022-06-30: Accounts Payable and Other Accrued Liabilities, Current $348.00K.
- 2022-03-31: Accounts Payable and Other Accrued Liabilities, Current $418.00K.
- 2021-12-31: Accounts Payable and Other Accrued Liabilities, Current $366.00K.
| Period end | Accounts Payable and Other Accrued Liabilities, Current | Accounts Payable and Other Accrued Liabilities, Current as first filed |
|---|---|---|
| 2022-09-30 | $261.00K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $348.00K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $418.00K 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $366.00K 10-Q · filed 2022-11-10 | |
| 2021-09-30 | $539.00K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $622.00K 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $616.00K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $667.00K 10-K · filed 2022-03-29 | |
| 2020-09-30 | $644.00K 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $529.00K 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $800.00K 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $899.00K 10-K · filed 2021-03-31 | |
| 2019-09-30 | $908.00K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $743.00K 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $746.00K 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $962.00K 10-K/A · filed 2020-03-31 | $1.01M 10-K · filed 2019-04-01 |
| 2017-12-31 | $436.00K 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |